We demonstrated that hepatic Il6r deficiency worsened MI, suggesting that IL-6 receptor antagonists such as TCZ could have a detrimental effect on cardiac function in the setting of MI by inhibiting hepatic IL-6 signaling. Here, IL6R is linked to myocardial infarction.